Grand Oak Canyons Distillery Ltd
GRANDOAKGrand Oak Canyons Distillery Ltd is printing record margins on a fuller multiple. From here the earnings must do all the lifting.
Biggest watch item: the net margin is the best this company has ever printed — every ratio flatters at record profitability, so the whole story leans on the net margin holding.
The price is in a confirmed uptrend (11 weeks in) while the P/BV sits at the 78th percentile of its own 8-year range. Underneath, the last four quarters read mixed, with the the net margin at −25.0%. What settles it: the next one or two quarters of delivery.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Grand Oak Canyons Distillery Ltd trades at ₹35.2, in a confirmed uptrend and 11 weeks into that stage. That is +2.2% against its own 200-day average. It sits at 26% of a 52-week range of ₹25 to ₹65. On relative strength it is currently behind the NIFTY 500 on a trailing-13-week view (3 weeks and counting).
Today the stock is in a confirmed uptrend — week 11 of stage 2, confirmed. At ₹35.2 it trades +2.2% versus its 200-day average and sits at 26% of its 52-week range (₹25–₹65).
Against the market, two honest reads. Cumulative: over the last 10.4 years the stock moved +395% while the NIFTY 500 moved +259% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (3 weeks and counting; last ahead the week of 2026-08-21) — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation For a bank we price the book, not the earnings: P/BV is what the market pays for each ₹1 of the bank's net worth. A bank below 1× book is priced below the value of what it owns, net of what it owes.
Grand Oak Canyons Distillery Ltd trades at 2.1× P/BV, at the pricey end of its own range (78th percentile). Its long-run median P/BV is 1.1×, measured across 8.1 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/BV of 2.1× is at the pricey end of its own range (78th percentile), against a long-run median of 1.1× measured over 8.1 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
The honest context for that discount: a bank earning about 0% on its equity is worth less per rupee of book, and the market has priced that in rather than overlooked it. The discount closes only if the returns themselves improve.
The price move, decomposed: over 5y, of the +28.9%/yr price move, ~+6.3%/yr came from book-value growth and ~+22.6 pp from the multiple (expanding). The split is the honest approximate (price return minus book-value growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is full against its own past, so the story rests on the book-value line underneath it, not the multiple.
Stage: No read Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Grand Oak Canyons Distillery Ltd reads as no read on its fundamental arc. Under eight usable quarters on the growth trio — not enough history for an honest trajectory read. The read is built from 8 quarters across 2 curves, on partial evidence.
Why it matters: with too little history, an honest page says so instead of guessing a trajectory.
Fewer than eight usable quarters on the growth curves — this page will not guess a trajectory from a stub of history.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +212.5% | — | — | — |
| Share price | −13.1% | +66.9% | +28.9% | +16.4% |
4-Factor Sector Score
38.9/100 — rank 24 of 34 in Finance & Investments - Others · 71% evidence confidence
Grand Oak Canyons Distillery Ltd scores 38.9 out of 100 against the 34 companies it is compared with in Finance & Investments - Others, ranking 24. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
The four contributions add to the total exactly: 23.4 + 4 + 0.7 + 10.8 = 38.9. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if ROA rolls over or gross NPA rises while sector-relative strength deteriorates.
Revenue For a bank, revenue is everything the franchise earns — interest on the loan book plus fee and other income.
Grand Oak Canyons Distillery Ltd reported ₹0.1 Cr of income in the Jun 26 quarter, +0.0% year on year. Over 9 years it has compounded at −0.4% a year. The last full year, FY26, came in at ₹0.3 Cr. The last four reported quarters add to ₹0.2 Cr.
FY26 revenue came in at ₹0.3 Cr (+212.5% on the year), capping 9 years at −0.4% compound. The latest quarter (Jun 26) printed ₹0.1 Cr, +0.0% year on year.
Pace check: the last four quarters averaged +0.0% growth against the decade's −0.4% — the current year is running in line with its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +175.0% over the last 4 quarters against −63.3%/yr over the last 8 — accelerating.
Net margin Net margin — what the bank keeps of every ₹100 of revenue after every cost, provision and tax. It is the cleanest single margin we can read for a lender.
Grand Oak Canyons Distillery Ltd's net margin is −25.0% in the Jun 26 quarter, +25.0 percentage points against the same quarter a year ago. That is the widest this company has ever printed on a full-year basis. Across 6 fiscal years the net margin has ranged −6,262.5% to 36.0%. The current quarter sits inside that band.
The latest quarter's net margin is −25.0%, +25.0 pp against the same quarter a year ago. Across 6 fiscal years the net margin has ranged −6,262.5%–36.0%, and FY26's 36.0% is the top of that band — a record year.
Why: the numbers show the net margin move clearly, but the cost lines behind it sit below what we hold — so we state the move without inventing its driver.
Worth repeating from the valuation section: cheap against its own history on record margins is not the same thing as cheap — a record margin flatters every ratio built on top of it.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Grand Oak Canyons Distillery Ltd posted a net loss of ₹0.02 Cr in the Jun 26 quarter. Full-year FY26 profit was ₹0.1 Cr. The 9-year compound rate is 1.3%. That loss is 25.0% of the quarter's revenue. The same quarter a year earlier lost ₹0.04 Cr. 5 of the last 12 reported quarters were loss-making.
Jun 26 profit was ₹−0.0 Cr, null year on year. On the full year, FY26 printed ₹0.1 Cr (null), and the 9-year compound rate is 1.3%.
Asset quality — the ladder Gross NPA is the slice of the loan book where repayments have stopped. Net NPA is what remains after the money already set aside against those loans. Falling is healing; rising is damage arriving.
Loan-book quality history is not available for Grand Oak Canyons Distillery Ltd, so this section names the gap rather than estimating a ratio. No gross or net non-performing-asset series is filed in a form this page can read, and none is inferred from the profit line. The income, margin and return sections above carry the evidence this business does report.
We do not hold quarterly loan-book quality numbers for this bank, so this section states that plainly rather than working around it.
Why: loan-book quality is the engine room of a bank, and its drivers — slippages, recoveries, provisioning — sit below what we hold for this name; the sections around it carry the reads we can stand behind.
The loan book We read the loan book through revenue — when the book grows, revenue grows with it. It is a rough proxy, and we say so: rate moves and fee swings can shift it a few points in any one year.
Grand Oak Canyons Distillery Ltd's revenue grew +212.5% in FY26 to ₹0.3 Cr, so the book is growing. The latest quarter ran +0.0% year on year. The net margin on that income is −25.0%, +25.0 percentage points against a year ago.
FY26 revenue was ₹0.3 Cr, +212.5% on the year, and the latest quarter ran +0.0% year on year. The net margin on that revenue is −25.0% this quarter (+25.0 pp YoY) — growth with a widening margin on it.
The synthesis: a lender compounds when the book grows while the margin holds and the loan book stays clean — gross NPA is the loan-quality read we carry here.
Returns on equity and assets Two numbers rate a bank: ROE — what it earns on shareholder money — and ROA — what it earns on everything it deploys. ROE above ~13–15% earns its keep; below that, growth builds book slowly.
Grand Oak Canyons Distillery Ltd earns a return on equity of 0% in FY26. Its trough over the ladder below was −1% in FY25. For a lender the balance sheet is the operating asset, so equity return and asset return have to be read together.
FY26 ROE came in at 0%, recovered from a FY25 trough of −1%. Return on assets is withheld on this page — its two source series disagree for this quarter. That return is below the bar a bank must clear to compound book value quickly — which is also the honest reason the stock trades where it does.
Why ROE moved: profit compounded 1.3% a year over 9 years while the equity base grew more slowly — earnings recovering faster than book value builds is what lifts ROE off a trough.
Debt
For a bank, borrowings are raw material, not a warning sign — solvency is read through the returns and the loan book. A manufacturer’s debt is a claim against its profits, so the debt-to-equity lens that works everywhere else misleads on a lender and is not applied here.
A manufacturer’s debt is a claim against its profits; a bank’s borrowings are its inventory — money taken in to be lent out. The debt lens that works everywhere else misleads here, so this page does not apply it. The solvency questions for a bank — is the loan book sound, is the equity earning — are read through the loan-book and returns sections above.
Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.
Domestic institutions cut 4.6 points of Grand Oak Canyons Distillery Ltd over 8 quarters, the biggest move on the register. That takes domestic institutions to 0.0% of the company. Promoters moved −1.6 points over the same window, to 0.0%. The register is read on the four disclosed classes only; nothing is inferred between filings.
The register over the last two years — Domestic institutions: −4.6 points over 8 quarters to 0.0%; Promoters: −1.6 points over 8 quarters to 0.0%. Note the structure: promoters hold under 20% — this is a widely-held company where institutions, not a family, set the direction.
🚨 Why the register moved: domestic institutions drove it (−4.6 points), alongside promoters (−1.6 points) — distribution into the market’s bid.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Grand Oak Canyons Distillery Ltd: the Z-score is omitted — it was built for manufacturers, not banks, and applying it here would be theatre. The Z-score was built for manufacturers and is not applied to banks and lenders, so solvency here is read from the capital and asset-quality lines instead.
The safety line in one sentence: the Z-score is omitted — it was built for manufacturers, not banks, and applying it here would be theatre.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Fedders Holding LtdFEDDERSHOL | 74.7/100Favorable setup80% evidence | BREAKING OUT | 25.1/35 Income -6.4% · PAT 100% 81% evidence | 18.3/25 ROA 10.9% · ROE 11.6% · GNPA — 68% evidence | 12.8/20 P/BV 1.35× · P/BV÷ROE 0.12 70% evidence | 18.5/20 RS sector 7.4% · RS bench 9.2% · 1Y 5.8%12 of 12 weeks ahead 100% evidence |
| Exact sum: 25.1 + 18.3 + 12.8 + 18.5 = 74.7 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence. | ||||||
| 2Abans Financial Services LtdAFSL | 70.5/100Favorable setup80% evidence | TURNING | 24.3/35 Income 100% · PAT 17.9% 81% evidence | 14.5/25 ROA 3.6% · ROE 8.3% · GNPA — 68% evidence | 17.0/20 P/BV 0.81× · P/BV÷ROE 0.1 100% evidence | 14.7/20 RS sector 21% · RS bench 0.4% · 1Y -8.3%0 of 10 weeks ahead 70% evidence |
| Exact sum: 24.3 + 14.5 + 17 + 14.7 = 70.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 3Gretex Corporate Services LtdGCSL | 63.8/100Mixed-positive evidence86% evidence | LEADER | 24.5/35 Income -19.4% · PAT 100% 81% evidence | 18.5/25 ROA 11.5% · ROE 12.7% · GNPA — 68% evidence | 1.6/20 P/BV 8.3× · P/BV÷ROE 0.65 100% evidence | 19.2/20 RS sector 56.1% · RS bench 60.7% · 1Y 97.3%11 of 12 weeks ahead 100% evidence |
| Exact sum: 24.5 + 18.5 + 1.6 + 19.2 = 63.8 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence. | ||||||
| 4Saraswati Commercial (India) LtdZSARACOM | 63.2/100Mixed-positive evidence80% evidence | BREAKING OUT | 30.6/35 Income 100% · PAT 100% 81% evidence | 15.2/25 ROA 7.6% · ROE 8.9% · GNPA — 68% evidence | 11.6/20 P/BV 1.07× · P/BV÷ROE 0.12 100% evidence | 5.8/20 RS sector -17% · RS bench -3.6% · 1Y -16.2%8 of 8 weeks ahead 70% evidence |
| Exact sum: 30.6 + 15.2 + 11.6 + 5.8 = 63.2 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -17% and the one-year return is -16.2%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 5BF Investment LtdBFINVEST | 60.1/100Mixed-positive evidence86% evidence | FADING | 27.3/35 Income 22.2% · PAT 100% 81% evidence | 12.1/25 ROA 3% · ROE 3.6% · GNPA — 68% evidence | 8.0/20 P/BV 0.2× · P/BV÷ROE 0.06 100% evidence | 12.7/20 RS sector 3.2% · RS bench 5.5% · 1Y -2.6%9 of 12 weeks ahead 100% evidence |
| Exact sum: 27.3 + 12.1 + 8 + 12.7 = 60.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 6Algoquant Fintech LtdALGOQUANT | 60.0/100Mixed-positive evidence74% evidence | BREAKING OUT | 20.0/35 Income 15.7% · PAT 100% 81% evidence | 20.3/25 ROA 12% · ROE 28.4% · GNPA — 68% evidence | 4.6/20 P/BV 13.51× · P/BV÷ROE 0.48 70% evidence | 15.1/20 RS sector 4.5% · RS bench 6.8% · 1Y -7.5%8 of 10 weeks ahead 70% evidence |
| Exact sum: 20 + 20.3 + 4.6 + 15.1 = 60 · Decision use: Strong business, demanding price: keep it on the quality list, but require either earnings upgrades or valuation compression. | ||||||
| 7CSL Finance LtdCSLFINANCE | 59.4/100Mixed-positive evidence90% evidence | BASING | 20.8/35 Income 19.7% · PAT 14.7% 76% evidence | 22.4/25 ROA 9% · ROE 14.9% · GNPA 0.9% 95% evidence | 12.0/20 P/BV 0.81× · P/BV÷ROE 0.05 100% evidence | 4.2/20 RS sector -14.3% · RS bench -12.5% · 1Y -25.1%1 of 12 weeks ahead 100% evidence |
| Exact sum: 20.8 + 22.4 + 12 + 4.2 = 59.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 8Master Trust LtdMASTERTR | 56.5/100Mixed-positive evidence80% evidence | TURNING | 13.3/35 Income 7% · PAT 8.1% 81% evidence | 18.9/25 ROA 5.6% · ROE 17.3% · GNPA — 68% evidence | 15.0/20 P/BV 1.36× · P/BV÷ROE 0.08 70% evidence | 9.3/20 RS sector -7% · RS bench -5.7% · 1Y -42%6 of 12 weeks ahead 100% evidence |
| Exact sum: 13.3 + 18.9 + 15 + 9.3 = 56.5 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 9STEL Holdings LtdSTEL | 54.1/100Mixed-positive evidence80% evidence | BREAKING OUT | 25.9/35 Income 20.7% · PAT 21.6% 81% evidence | 9.0/25 ROA 1.2% · ROE 1.2% · GNPA — 68% evidence | 2.9/20 P/BV 0.7× · P/BV÷ROE 0.59 100% evidence | 16.3/20 RS sector 20.5% · RS bench 24.4% · 1Y 30.3%10 of 10 weeks ahead 70% evidence |
| Exact sum: 25.9 + 9 + 2.9 + 16.3 = 54.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 10Mufin Green Finance LtdMUFIN | 52.6/100Mixed-positive evidence82% evidence | LEADER | 24.0/35 Income 27.8% · PAT 100% 86% evidence | 11.2/25 ROA 1.3% · ROE 6.7% · GNPA — 72% evidence | 3.9/20 P/BV 4.66× · P/BV÷ROE 0.7 70% evidence | 13.5/20 RS sector 14.4% · RS bench 17.5% · 1Y 60.5%11 of 12 weeks ahead 100% evidence |
| Exact sum: 24 + 11.2 + 3.9 + 13.5 = 52.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 11Dolat Algotech LtdDOLATALGO | 52.5/100Mixed-positive evidence80% evidence | BASING | 8.5/35 Income -11.6% · PAT -21.2% 81% evidence | 18.1/25 ROA 8.5% · ROE 12.1% · GNPA — 68% evidence | 17.1/20 P/BV 1.08× · P/BV÷ROE 0.09 100% evidence | 8.8/20 RS sector -0.8% · RS bench -8.7% · 1Y -15.5%0 of 10 weeks ahead 70% evidence |
| Exact sum: 8.5 + 18.1 + 17.1 + 8.8 = 52.5 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 12Balmer Lawrie Investment LtdBLIL | 51.4/100Mixed-positive evidence86% evidence | BASING | 14.8/35 Income 8.8% · PAT 4.1% 81% evidence | 18.3/25 ROA 7.9% · ROE 12.7% · GNPA — 68% evidence | 13.9/20 P/BV 1.06× · P/BV÷ROE 0.08 100% evidence | 4.4/20 RS sector -7.3% · RS bench -5.1% · 1Y -26.9%0 of 12 weeks ahead 100% evidence |
| Exact sum: 14.8 + 18.3 + 13.9 + 4.4 = 51.4 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 13Bengal & Assam Company LtdBENGALASM | 51.3/100Mixed-positive evidence64% evidence | 16.7/35 Income 12.1% · PAT 3.4% 62% evidence | 12.8/25 ROA — · ROE 8.1% · GNPA — 34% evidence | 15.9/20 P/BV 0.67× · P/BV÷ROE 0.08 100% evidence | 5.9/20 RS sector -9.4% · RS bench -6.2% · 1Y -26%1 of 8 weeks ahead 70% evidence | |
| Exact sum: 16.7 + 12.8 + 15.9 + 5.9 = 51.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 14PTC India Financial Services LtdPFS | 50.8/100Mixed-positive evidence80% evidence | BASING | 12.4/35 Income -22.7% · PAT -27.8% 81% evidence | 16.8/25 ROA 6.5% · ROE 11% · GNPA — 68% evidence | 15.8/20 P/BV 0.57× · P/BV÷ROE 0.05 100% evidence | 5.8/20 RS sector -7.1% · RS bench -12% · 1Y -27.9%1 of 10 weeks ahead 70% evidence |
| Exact sum: 12.4 + 16.8 + 15.8 + 5.8 = 50.8 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 15Consolidated Finvest & Holdings LtdCONSOFINVT | 48.1/100Mixed-negative evidence86% evidence | BREAKING OUT | 8.1/35 Income -9.1% · PAT -43.9% 81% evidence | 13.7/25 ROA 4.3% · ROE 5% · GNPA — 68% evidence | 7.1/20 P/BV 0.84× · P/BV÷ROE 0.17 100% evidence | 19.2/20 RS sector 36.6% · RS bench 40.7% · 1Y 54.7%11 of 12 weeks ahead 100% evidence |
| Exact sum: 8.1 + 13.7 + 7.1 + 19.2 = 48.1 · Decision use: Price leads the evidence: RS versus the benchmark is 40.7%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 16Industrial & Prudential Investment Company LtdINDPRUD | 45.6/100Mixed-negative evidence80% evidence | ASLEEP | 12.5/35 Income -40% · PAT -3.2% 81% evidence | 15.6/25 ROA 7.3% · ROE 7.7% · GNPA — 68% evidence | 6.3/20 P/BV 1.23× · P/BV÷ROE 0.16 100% evidence | 11.2/20 RS sector -3.5% · RS bench 6% · 1Y -1.7%0 of 9 weeks ahead 70% evidence |
| Exact sum: 12.5 + 15.6 + 6.3 + 11.2 = 45.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 17Finkurve Financial Services LtdFINKURVE | 45.3/100Mixed-negative evidence74% evidence | BREAKING OUT | 21.0/35 Income 59.6% · PAT 62.2% 81% evidence | 14.1/25 ROA 2.1% · ROE 9.4% · GNPA — 68% evidence | 6.0/20 P/BV 2.95× · P/BV÷ROE 0.31 70% evidence | 4.2/20 RS sector -34.3% · RS bench -8.4% · 1Y -29.3%5 of 11 weeks ahead 70% evidence |
| Exact sum: 21 + 14.1 + 6 + 4.2 = 45.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 18VLS Finance LtdVLSFINANCE | 44.4/100Mixed-negative evidence80% evidence | BREAKING OUT | 18.1/35 Income -8.4% · PAT 91.7% 81% evidence | 7.5/25 ROA 1% · ROE 0.9% · GNPA — 68% evidence | 4.9/20 P/BV 0.36× · P/BV÷ROE 0.38 100% evidence | 13.9/20 RS sector 9.4% · RS bench -1% · 1Y 9.4%4 of 10 weeks ahead 70% evidence |
| Exact sum: 18.1 + 7.5 + 4.9 + 13.9 = 44.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 19PTL Enterprises LtdPTL | 44.4/100Mixed-negative evidence75% evidence | ASLEEP | 16.4/35 Income 0% · PAT 13.5% 52% evidence | 13.8/25 ROA 3.3% · ROE 5.5% · GNPA — 68% evidence | 8.0/20 P/BV 0.6× · P/BV÷ROE 0.11 100% evidence | 6.2/20 RS sector -3.9% · RS bench -1.5% · 1Y -3%1 of 12 weeks ahead 100% evidence |
| Exact sum: 16.4 + 13.8 + 8 + 6.2 = 44.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 20PNB Gilts LtdPNBGILTS | 41.4/100Mixed-negative evidence80% evidence | ASLEEP | 9.1/35 Income -5.3% · PAT -69.7% 81% evidence | 9.9/25 ROA 0.7% · ROE 11.1% · GNPA — 68% evidence | 15.3/20 P/BV 0.85× · P/BV÷ROE 0.08 100% evidence | 7.1/20 RS sector -13.5% · RS bench -1.1% · 1Y -17.8%5 of 10 weeks ahead 70% evidence |
| Exact sum: 9.1 + 9.9 + 15.3 + 7.1 = 41.4 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 21NBI Industrial Finance Company LtdNBIFIN | 41.1/100Mixed-negative evidence69% evidence | TURNING | 20.8/35 Income 55.5% · PAT 65.2% 33% evidence | 6.1/25 ROA 0.3% · ROE 0.4% · GNPA — 68% evidence | 4.6/20 P/BV 0.23× · P/BV÷ROE 0.55 100% evidence | 9.6/20 RS sector -5.3% · RS bench -3.4% · 1Y -20%4 of 12 weeks ahead 100% evidence |
| Exact sum: 20.8 + 6.1 + 4.6 + 9.6 = 41.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 22Authum Investment & Infrastructure LtdAIIL | 40.9/100Mixed-negative evidence70% evidence | FADING | 8.6/35 Income -34.6% · PAT -48.8% 62% evidence | 15.2/25 ROA — · ROE 12.8% · GNPA — 34% evidence | 5.5/20 P/BV 3.14× · P/BV÷ROE 0.24 100% evidence | 11.6/20 RS sector 1.4% · RS bench 3.6% · 1Y -11.3%9 of 12 weeks ahead 100% evidence |
| Exact sum: 8.6 + 15.2 + 5.5 + 11.6 = 40.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 23Capital India Finance LtdCIFL | 39.7/100Thin evidence · provisional57% evidence | BASING | 17.7/35 Income -1.5% · PAT 100% 52% evidence | 8.8/25 ROA 1.7% · ROE -8.6% · GNPA — 68% evidence | 9.2/20 P/BV 1.17× · P/BV÷ROE — 40% evidence | 4.0/20 RS sector -17.3% · RS bench -28.9% · 1Y -39.2%0 of 10 weeks ahead 70% evidence |
| Exact sum: 17.7 + 8.8 + 9.2 + 4 = 39.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 24Grand Oak Canyons Distillery Ltdthis pageGRANDOAK | 38.9/100Mixed-negative evidence71% evidence | BREAKING OUT | 23.4/35 Income 100% · PAT 100% 54% evidence | 4.0/25 ROA 0.1% · ROE 0% · GNPA — 72% evidence | 0.7/20 P/BV 2.15× · P/BV÷ROE 215 100% evidence | 10.8/20 RS sector 2% · RS bench -5% · 1Y -13.4%9 of 9 weeks ahead 70% evidence |
| Exact sum: 23.4 + 4 + 0.7 + 10.8 = 38.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 25The Investment Trust of India LtdTHEINVEST | 37.9/100Mixed-negative evidence75% evidence | TURNING | 11.7/35 Income -22.4% · PAT -13.9% 52% evidence | 11.9/25 ROA 2.7% · ROE 4% · GNPA — 68% evidence | 8.0/20 P/BV 0.69× · P/BV÷ROE 0.17 100% evidence | 6.3/20 RS sector -12.6% · RS bench -10.9% · 1Y -36.9%0 of 12 weeks ahead 100% evidence |
| Exact sum: 11.7 + 11.9 + 8 + 6.3 = 37.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 26Nalwa Sons Investments LtdNSIL | 36.2/100Mixed-negative evidence76% evidence | TURNING | 18.8/35 Income -20.3% · PAT 37.2% 86% evidence | 5.9/25 ROA 0.3% · ROE 0.3% · GNPA — 72% evidence | 5.0/20 P/BV 0.19× · P/BV÷ROE 0.56 70% evidence | 6.5/20 RS sector -6.7% · RS bench -7.8% · 1Y -21.5%0 of 10 weeks ahead 70% evidence |
| Exact sum: 18.8 + 5.9 + 5 + 6.5 = 36.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 27Prime Securities LtdPRIMESECU | 34.2/100Adverse evidence86% evidence | ASLEEP | 8.9/35 Income 14.4% · PAT -80% 81% evidence | 13.4/25 ROA 4.6% · ROE 4.1% · GNPA — 68% evidence | 3.2/20 P/BV 3.74× · P/BV÷ROE 0.91 100% evidence | 8.7/20 RS sector -1.6% · RS bench 0.9% · 1Y 7.1%0 of 12 weeks ahead 100% evidence |
| Exact sum: 8.9 + 13.4 + 3.2 + 8.7 = 34.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 28Crest Ventures LtdCREST | 33.0/100Adverse evidence86% evidence | ASLEEP | 7.1/35 Income -33.2% · PAT -49.3% 81% evidence | 12.4/25 ROA 2.5% · ROE 3.8% · GNPA — 68% evidence | 8.0/20 P/BV 0.77× · P/BV÷ROE 0.2 100% evidence | 5.5/20 RS sector -4.1% · RS bench -1.8% · 1Y -5.7%2 of 12 weeks ahead 100% evidence |
| Exact sum: 7.1 + 12.4 + 8 + 5.5 = 33 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 29Kiran Vyapar LtdKIRANVYPAR | 32.6/100Adverse evidence64% evidence | BREAKING OUT | 10.2/35 Income 0.9% · PAT -80% 62% evidence | 7.3/25 ROA 1.1% · ROE 0.1% · GNPA — 68% evidence | 3.4/20 P/BV 0.25× · P/BV÷ROE 5 100% evidence | 11.7/20 RS sector — · RS bench 5.2% · 1Y —4 of 7 weeks ahead 25% evidence |
| Exact sum: 10.2 + 7.3 + 3.4 + 11.7 = 32.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 30Dhunseri Investments LtdDHUNINV | 30.8/100Adverse evidence73% evidence | BREAKING OUT | 15.5/35 Income -12.3% · PAT 17.1% 62% evidence | 5.0/25 ROA -0.5% · ROE 0.7% · GNPA — 68% evidence | 5.3/20 P/BV 0.22× · P/BV÷ROE 0.33 100% evidence | 5.0/20 RS sector -34.7% · RS bench -3.5% · 1Y -29.7%6 of 6 weeks ahead 70% evidence |
| Exact sum: 15.5 + 5 + 5.3 + 5 = 30.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 31Systematix Corporate Services LtdSYSTMTXC | 29.3/100Adverse evidence74% evidence | TURNING | 9.4/35 Income 14.4% · PAT -80% 81% evidence | 12.4/25 ROA 3.2% · ROE 4.6% · GNPA — 68% evidence | 4.1/20 P/BV 3.15× · P/BV÷ROE 0.68 70% evidence | 3.4/20 RS sector -38.5% · RS bench -20.7% · 1Y -40.2%1 of 10 weeks ahead 70% evidence |
| Exact sum: 9.4 + 12.4 + 4.1 + 3.4 = 29.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 32Oswal Green Tech LtdOSWALGREEN | 27.9/100Adverse evidence75% evidence | BASING | 8.8/35 Income -46.8% · PAT -80% 52% evidence | 8.2/25 ROA 1.1% · ROE 1.5% · GNPA — 68% evidence | 8.0/20 P/BV 0.22× · P/BV÷ROE 0.15 100% evidence | 2.9/20 RS sector -29.4% · RS bench -28.2% · 1Y -50.2%0 of 12 weeks ahead 100% evidence |
| Exact sum: 8.8 + 8.2 + 8 + 2.9 = 27.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 33Spice Lounge Food Works LtdSPICELOUNG | 44.4/100Thin evidence · provisional44% evidence | 20.2/35 Income 20.9% · PAT 100% 22% evidence | 12.0/25 ROA — · ROE 8.4% · GNPA — 34% evidence | 3.3/20 P/BV 15.85× · P/BV÷ROE 1.9 70% evidence | 8.9/20 RS sector 0.7% · RS bench -20.9% · 1Y -43%2 of 12 weeks ahead 70% evidence | |
| Exact sum: 20.2 + 12 + 3.3 + 8.9 = 44.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 34Eraaya Lifespaces LtdEBIX | 39.5/100Thin evidence · provisional22% evidence | 17.5/35 Income — · PAT — 0% evidence | 9.3/25 ROA — · ROE -809% · GNPA — 26% evidence | 9.2/20 P/BV 6.36× · P/BV÷ROE — 10% evidence | 3.5/20 RS sector -34.1% · RS bench -39.5% · 1Y -45.3%8 of 12 weeks ahead to 2026-03-08 70% evidence | |
| Exact sum: 17.5 + 9.3 + 9.2 + 3.5 = 39.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. Financial companies use P/BV÷ROE and asset quality; PEG, industrial OPM and ROCE are excluded. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is Grand Oak Canyons Distillery Ltd's share price today?
Grand Oak Canyons Distillery Ltd trades at ₹35.2, −13.1% over the past year. The company is valued at ₹1,824 Cr. The stock sits at 26% of its 52-week range of ₹25–₹65, +2.2% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 11 weeks in. — as of 11 September 2026.
What were Grand Oak Canyons Distillery Ltd's latest quarterly results?
Grand Oak Canyons Distillery Ltd reported total income of ₹0.1 Cr and a net loss of ₹0.0 Cr for the Jun 26 quarter. The net margin was −25.0%, 25.0 pp higher than a year earlier. — as of 11 September 2026.
What is Grand Oak Canyons Distillery Ltd's revenue?
Grand Oak Canyons Distillery Ltd reported revenue of ₹0.1 Cr in the Jun 26 quarter, +0.0% year on year. For the full FY26 fiscal year, revenue was ₹0.3 Cr (+212.5%). Over the last 9 years revenue compounded at −0.4% a year. — as of 11 September 2026.
What is Grand Oak Canyons Distillery Ltd's profit?
Grand Oak Canyons Distillery Ltd earned ₹−0.0 Cr of net profit in the Jun 26 quarter. Full-year FY26 profit was ₹0.1 Cr. The net margin ran −25.0% in the latest quarter. — as of 11 September 2026.
What is Grand Oak Canyons Distillery Ltd's market cap?
Grand Oak Canyons Distillery Ltd's market capitalisation is ₹1,824 Cr at a share price of ₹35.2. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 11 September 2026.
What is Grand Oak Canyons Distillery Ltd's P/BV ratio?
Grand Oak Canyons Distillery Ltd trades at a P/BV of 2.1×, at the 78th percentile of its own 8-year range, against a long-run median of 1.1×. This is a comparison with the stock's own history, not a value call — as of 11 September 2026.
Does Grand Oak Canyons Distillery Ltd pay a dividend?
No — Grand Oak Canyons Distillery Ltd has recorded a dividend payout of 0% of profit in each of its last 6 reported fiscal years, so there is no payout history to quote. That is a reading of the filed annual statements, not an estimate. — as of 11 September 2026.
Is Grand Oak Canyons Distillery Ltd overvalued?
On its own history, Grand Oak Canyons Distillery Ltd looks expensive: its P/BV of 2.1× sits at the 78th percentile of its 8-year range (long-run median 1.1×). That is a percentile read against the stock's own past, not a price opinion or a direction call. One caveat: the net margin is the best this company has ever printed — cheap on record margins is not the same thing as cheap. — as of 11 September 2026.
How is Grand Oak Canyons Distillery Ltd performing?
Grand Oak Canyons Distillery Ltd is in a confirmed uptrend, 11 weeks in. Against the NIFTY 500 it has been behind on a trailing-13-week view for 3 weeks. This describes what the data did, not a rating. — as of 11 September 2026.
Is Grand Oak Canyons Distillery Ltd in an uptrend?
Yes — the price is in a confirmed uptrend (week 11 of stage 2), trading +2.2% versus its 200-day average and at 26% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 11 September 2026.
Is Grand Oak Canyons Distillery Ltd beating the market?
Not lately — on a trailing-13-week view Grand Oak Canyons Distillery Ltd is currently behind the NIFTY 500 (3 weeks and counting; last ahead the week of 2026-08-21), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.4 years the stock moved +395% against the NIFTY 500's +259% — ahead of the index over the full window. — as of 11 September 2026.
Will Grand Oak Canyons Distillery Ltd's share price go up?
This page publishes no price forecast for Grand Oak Canyons Distillery Ltd. What it measures instead: the share price is ₹35.2, the price is in a confirmed uptrend 11 weeks in. Its P/BV of 2.1× sits at the 78th percentile of its own 8-year range. — as of 11 September 2026.
Who owns Grand Oak Canyons Distillery Ltd?
Promoters hold 0.0% of Grand Oak Canyons Distillery Ltd, foreign institutions null%, domestic institutions 0.0% and the public 100.0% (latest quarter). The biggest move on the register over the last two years: Domestic institutions cut 4.6 points over 8 quarters. — as of 11 September 2026.
Where is Grand Oak Canyons Distillery Ltd in its business cycle?
Grand Oak Canyons Distillery Ltd's FY26 net margin was 36.0%, against a 6-year band of −6,262.5%–36.0%: the top of the band — a record year. Record profitability is late-cycle territory: every ratio flatters at the top, and the story leans on margins holding. The latest quarter ran −25.0%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 11 September 2026.
What could break the Grand Oak Canyons Distillery Ltd story?
Biggest watch item: the net margin is the best this company has ever printed — every ratio flatters at record profitability, so the whole story leans on the net margin holding. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 11 September 2026.
Is Grand Oak Canyons Distillery Ltd a stock worth studying right now?
This is not investment advice. The machine read: Grand Oak Canyons Distillery Ltd is printing record margins on a fuller multiple. From here the earnings must do all the lifting. The sharpest open question: the next one or two quarters of delivery. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 11 September 2026.
Not SEBI Registered !! Not Investment advice !!